Cargando…

The association between serum testosterone levels and metabolic syndrome among women

BACKGROUND: This study aimed to investigate the relationship between total serum testosterone level (TT) and metabolic syndrome (MetS) among adult female population. Subgroup analysis further stratified the population by menopausal status to address the potential hormonal difference in postmenopausa...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Junxiao, Peng, Qiaohua, Yang, Xinyun, Yang, Chunbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937283/
https://www.ncbi.nlm.nih.gov/pubmed/33676567
http://dx.doi.org/10.1186/s13098-021-00643-6
_version_ 1783661358736211968
author Liang, Junxiao
Peng, Qiaohua
Yang, Xinyun
Yang, Chunbo
author_facet Liang, Junxiao
Peng, Qiaohua
Yang, Xinyun
Yang, Chunbo
author_sort Liang, Junxiao
collection PubMed
description BACKGROUND: This study aimed to investigate the relationship between total serum testosterone level (TT) and metabolic syndrome (MetS) among adult female population. Subgroup analysis further stratified the population by menopausal status to address the potential hormonal difference in postmenopausal women. METHODS: A total of 1966 participants from the National Health and Nutrition Examination Survey (NHANES) 2011–2012 cycle was included for analysis in this study. MetS was defined based on the National Cholesterol Education Program Adult Treatment Panel III guidelines. Serum TT was collected during the physical examination of the NHANES program and divided into quartiles (Q) in this analysis. Menopausal status was determined based on NHANES Reproductive Health Questionnaire. Logistic regression models were applied for analysis. RESULTS: The odds of MetS in Q2: 12.99–19.38 ng/mL (OR = 0.641, 95%CI 0.493–0.835, P < 0.01), Q3: 19.39–28.38 ng/mL (OR = 0.476, 95%CI 0.362–0.626, P < 0.001), and Q4: ≥28.40 ng/mL (OR = 0.390, 95%CI 0.294–0.517, P < 0.001) were statistically lower compared to the reference Q1: <12.99 ng/mL. For the postmenopausal group, a significantly lower odds of MetS was observed in the Q2 (OR = 0.689, 95%CI 0.486–0.977, P < 0.05) and Q4 (OR = 0.606, 95%CI 0.399–0.922, P < 0.05), while the odds of Q3 (OR = 0.439, 95%CI 0.248–0.779, P < 0.01) and Q4 (OR = 0.464, 95%CI 0.261–0.825, P < 0.01) were significantly lower than the reference Q1 in the premenopausal group. CONCLUSIONS: Elevated TT levels are associated with incremental reductions in the odds of metabolic syndrome among adult females. Although, serum testosterone level is associated with the occurrence of metabolic syndrome in both the postmenopausal and the premenopausal group, the patterns of the relationship are different.
format Online
Article
Text
id pubmed-7937283
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79372832021-03-09 The association between serum testosterone levels and metabolic syndrome among women Liang, Junxiao Peng, Qiaohua Yang, Xinyun Yang, Chunbo Diabetol Metab Syndr Research BACKGROUND: This study aimed to investigate the relationship between total serum testosterone level (TT) and metabolic syndrome (MetS) among adult female population. Subgroup analysis further stratified the population by menopausal status to address the potential hormonal difference in postmenopausal women. METHODS: A total of 1966 participants from the National Health and Nutrition Examination Survey (NHANES) 2011–2012 cycle was included for analysis in this study. MetS was defined based on the National Cholesterol Education Program Adult Treatment Panel III guidelines. Serum TT was collected during the physical examination of the NHANES program and divided into quartiles (Q) in this analysis. Menopausal status was determined based on NHANES Reproductive Health Questionnaire. Logistic regression models were applied for analysis. RESULTS: The odds of MetS in Q2: 12.99–19.38 ng/mL (OR = 0.641, 95%CI 0.493–0.835, P < 0.01), Q3: 19.39–28.38 ng/mL (OR = 0.476, 95%CI 0.362–0.626, P < 0.001), and Q4: ≥28.40 ng/mL (OR = 0.390, 95%CI 0.294–0.517, P < 0.001) were statistically lower compared to the reference Q1: <12.99 ng/mL. For the postmenopausal group, a significantly lower odds of MetS was observed in the Q2 (OR = 0.689, 95%CI 0.486–0.977, P < 0.05) and Q4 (OR = 0.606, 95%CI 0.399–0.922, P < 0.05), while the odds of Q3 (OR = 0.439, 95%CI 0.248–0.779, P < 0.01) and Q4 (OR = 0.464, 95%CI 0.261–0.825, P < 0.01) were significantly lower than the reference Q1 in the premenopausal group. CONCLUSIONS: Elevated TT levels are associated with incremental reductions in the odds of metabolic syndrome among adult females. Although, serum testosterone level is associated with the occurrence of metabolic syndrome in both the postmenopausal and the premenopausal group, the patterns of the relationship are different. BioMed Central 2021-03-06 /pmc/articles/PMC7937283/ /pubmed/33676567 http://dx.doi.org/10.1186/s13098-021-00643-6 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Liang, Junxiao
Peng, Qiaohua
Yang, Xinyun
Yang, Chunbo
The association between serum testosterone levels and metabolic syndrome among women
title The association between serum testosterone levels and metabolic syndrome among women
title_full The association between serum testosterone levels and metabolic syndrome among women
title_fullStr The association between serum testosterone levels and metabolic syndrome among women
title_full_unstemmed The association between serum testosterone levels and metabolic syndrome among women
title_short The association between serum testosterone levels and metabolic syndrome among women
title_sort association between serum testosterone levels and metabolic syndrome among women
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937283/
https://www.ncbi.nlm.nih.gov/pubmed/33676567
http://dx.doi.org/10.1186/s13098-021-00643-6
work_keys_str_mv AT liangjunxiao theassociationbetweenserumtestosteronelevelsandmetabolicsyndromeamongwomen
AT pengqiaohua theassociationbetweenserumtestosteronelevelsandmetabolicsyndromeamongwomen
AT yangxinyun theassociationbetweenserumtestosteronelevelsandmetabolicsyndromeamongwomen
AT yangchunbo theassociationbetweenserumtestosteronelevelsandmetabolicsyndromeamongwomen
AT liangjunxiao associationbetweenserumtestosteronelevelsandmetabolicsyndromeamongwomen
AT pengqiaohua associationbetweenserumtestosteronelevelsandmetabolicsyndromeamongwomen
AT yangxinyun associationbetweenserumtestosteronelevelsandmetabolicsyndromeamongwomen
AT yangchunbo associationbetweenserumtestosteronelevelsandmetabolicsyndromeamongwomen